Trial Profile
Phase II Study of Recombinant Endostatin Combined With Modified FOLFOX6 in Advanced Colorectal Cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 27 Sep 2023
Price :
$35
*
At a glance
- Drugs Endostatin (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use
- 26 Nov 2013 Planned end date changed from 1 Mar 2014 to 1 Sep 2014 as reported by ClinicalTrials.gov.
- 13 Feb 2012 New trial record